Menu Back toInternational Coalition of Medicines Regulatory Authorities (ICMRA): Harnessing Achievements During COVID-19 for the Future

DIA 2021 Global Annual Meeting

International Coalition of Medicines Regulatory Authorities (ICMRA): Harnessing Achievements During COVID-19 for the Future

Session Chair(s)

Agnès Saint-Raymond, DrMed

Agnès Saint-Raymond, DrMed

  • Head of Division International Affairs
  • European Medicines Agency, Netherlands
There is an on-going need for coordination, ownership, and oversight of the various changes, improvements, and flexibilities that have emerged through the pandemic. While this is a multipronged problem, the regulatory coordination, flexibility and speed are paramount. ICMRA and their achievements that were the most visible during COVID-19 will be discussed including global regulatory collaboration and its impact during the pandemic. Additionally, a panel discussion on the role of ICMRA for the future of convergence, and the impact of achievements during COVID-19 on its strategic initiatives and technical workstreams will be included.
Learning Objective : Identify the role and activities of ICMRA; Discuss the collaboration within ICMRA during COVID-19; Describe ICMRA achievements beyond COVID-19.

Speaker(s)

Charbel Haber, PhD, MBA, MPH

How Regulatory Cooperation and Convergence has Helped COVID Vaccines Gain Authorization Globally

Charbel Haber, PhD, MBA, MPH

  • Senior Vice President, Head of Regulatory Affairs
  • Moderna, United States
Sean Curtis, MD, MPH

COVID-19 Experience and How ICMRA’s Efforts Supported Development of Vaccines and Therapeutics

Sean Curtis, MD, MPH

  • Senior Vice President, Global Regulatory Affairs and Clinical Safety
  • Merck & Co., Inc., United States
Kyung Won Seo

ICMRA’s Achievements from the Perspective of NiFDS

Kyung Won Seo

  • Director General, National Institute of Food and Drug Safety Evaluation
  • Ministiry of Food and Drug Safety, Korea, Republic of
John Skerritt, PhD

ICMRA Vaccine Pharmacovigilance

John Skerritt, PhD

  • Deputy Secretary for Health Products Regulation
  • Commonwealth Department of Health, Australia
Antonio Barra Torres, MD

ICMRA's Achievements From ANVISA's Perspective

Antonio Barra Torres, MD

  • President Director
  • ANVISA, Brazil
Emer Cooke, MBA, MSc

ICMRA's Achievements From EMA's Perspective

Emer Cooke, MBA, MSc

  • Chair, ICMRA; Executive Director
  • European Medicines Agency, Netherlands
Pierre Sabourin, MBA

ICMRA's Achievements From Health Canada's Perspective

Pierre Sabourin, MBA

  • Assistant Deputy Minister, Health Products and Food Branch
  • Health Canada, Canada